Tags: Drug.

Ladostigil (TV-3326) is a novel neuroprotective agent being investigated for the treatment of neurodegenerative disorders like Alzheimer’s disease Lewy body disease and Parkinson’s disease. It acts as a reversible acetylcholinesterase and butyrylcholinesterase inhibitor and an irreversible monoamine oxidase B inhibitor and combines the mechanisms of action of older drugs like rivastigmine and rasagiline into a single molecule.

Ladostigil.png
ATC prefix
none
CAS number
209349-27-4
FDA UNII code
SW3H1USR4Q
IUPAC name
[(3R)-3-(prop-2-ynylamino)indan-5-yl]-N-propylcarbamate
PubChem
208907

Loading...

This page contains content from the copyrighted Wikipedia article "Ladostigil"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.